Wellington Management Group
RGLS

Wellington Management Group’s Regulus Therapeutics RGLS Stock Holding History

Wellington Management Group’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-39,029
Closed -$10.5M – 2301
2016
Q4 		$10.5M Buy
39,029
+289
+0.7% +$93.9K ﹤0.01% 1181
2016
Q3 		$15.3M Sell
38,740
-1,978
-5% -$814K ﹤0.01% 1054
2016
Q2 		$14.1M Buy
40,718
+7,122
+21% +$5.1M ﹤0.01% 1055
2016
Q1 		$27.9M Sell
33,596
-1,519
-4% -$1.21M 0.01% 824
2015
Q4 		$36.7M Sell
35,115
-35
-0.1% -$35.1K 0.01% 769
2015
Q3 		$27.6M Sell
35,150
-5,295
-13% -$5.43M 0.01% 864
2015
Q2 		$53.2M Sell
40,445
-4,643
-10% -$7.49M 0.01% 699
2015
Q1 		$91.7M Buy
45,088
+13,595
+43% +$29.5M 0.02% 541
2014
Q4 		$60.6M Buy
31,493
+22,735
+260% +$40.4M 0.02% 670
2014
Q3 		$7.18M Buy
8,758
+924
+12% +$781K ﹤0.01% 1338
2014
Q2 		$7.56M Buy
7,834
+1,626
+26% +$1.39M ﹤0.01% 1331
2014
Q1 		$6.72M Sell
6,208
-498
-7% -$552K ﹤0.01% 1360
2013
Q4 		$5.95M Buy
+6,706
New +$5.77M ﹤0.01% 1405

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group's RGLS Position: Q1 2017 in Review

Wellington Management Group sold out of Regulus Therapeutics (RGLS) in Q1 2017, closing a stake of 39,029 shares — an estimated $10.5M sold.

Wellington Management Group first reported a position in RGLS in Q4 2013 and held it in 13 quarters. The position peaked at $91.7M in Q1 2015. 58 funds tracked by Wall St. Rank hold RGLS as of Q1 2017.

  • Wellington Management Group reported no remaining Regulus Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Wellington Management Group sold 39,029 Regulus Therapeutics shares in Q1 2017, an estimated $10.5M.
  • Wellington Management Group first reported a position in Regulus Therapeutics in Q4 2013 and held it in 13 quarters.
  • Wellington Management Group's Regulus Therapeutics position peaked at $91.7M in Q1 2015.
  • 58 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2017.

Based on Wellington Management Group's 13F filing for Q1 2017, filed 11 May 2017.